Skip to main content
Quest Diagnostics

Improved Automated Extraction and High-Throughput Analysis of ∆9-Tetrahydrocannabinol (∆9-THC) in Oral Fluid

Society for Forensic Toxicologists
SOFT2022

Cleveland, OH, October 30 - Nov 4, 2022

Oral presentation: Improved automated extraction and high-throughput analysis of ∆9-tetrahydrocannabinol (∆9-THC) in oral fluid 

Authors: Muslin O, Sample B, Edinboro LE, Jones AH, Smith MP, Bartock SH

Specialties: Prescription Drug Monitoring, Toxicology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.